Clinical Trial Update: Study of Icotinib Hydrochloride in Treating Patients With Recurrent or Metastatic Esophageal Cancer After Failure of Conventional Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating icotinib hydrochloride in recurrent or metastatic esophageal squamous cell carcinoma after failure of conventional chemotherapy has bee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Icotinib hydrochloride (icotinib)

Snippet

Sponsor: Yuhong Li | Conditions: Esophageal Squamous Cell Carcinoma | Phase 2 | Status: COMPLETED